Ls. Lamb et al., Influence of T cell depletion method on circulating gamma delta T cell reconstitution and potential role in the graft-versus-leukemia effect, CYTOTHERAPY, 1(1), 1999, pp. 7-19
Citations number
30
Categorie Soggetti
Hematology,"Medical Research Diagnosis & Treatment
Background
Our laboratory previously reported that leukemia patients who developed gre
ater than or equal to 10% gamma delta(+) T cells during the first six-month
s after receiving an anti-TCR alpha beta T-cell-depleted (TCD) graft from a
partially mismatched related donor (PMRD) had a disease-free survival (DFS
) advantage. These gamma delta(+) T cells were V delta 1(+)CD3(+)CD4(-)CD8(
-)CD69(+)HLADR(+) and are cytotoxic to K562 cells.
Methods
In order to determine wheather the anti-alpha beta TCD regimen was associat
ed with these findings, we recieved TCD PMRD grafts using gamma delta(+) T
cells from patients who recieved TCD PMRD grafts using the anti-TCR alpha b
eta MAb T10B9-1A31 (previously reported) with similar patients who received
grafts using the anti-CD3 MAb OKT3.
Results
Increased cytotoxic V delta 1(+) T cells were seen in 10 of 43 T10B9 TCD pa
tients compared to 7 of 100 in the OKT3 TCP group (23% versus 7%, p = 0.010
). T10B9 patients with incresed gamma delta(+) T cells also exhibited a hig
her range of increased gamma delta(+) T cells and the length of time the ga
mma delta(+) T cells remained high was longer when compared to OKT3 patient
s. Patients with increased gamma delta(+) T cells whose grafts were T-cell
depleted with T-cell showed a significant decrease in relapse (p = 0.038).
Similar rates and reduction in relapse were seen in OKT3 TCD patients, alth
ough significant was not reached due to the small number of patients with i
ncreased gamma delta(+) T cells. Estimated 3 year disease-free survival was
significantly improved in T10B9 patients with increased gamma delta(+) T c
ells (0.79 versus 0.31, p = 0.009), a trend also seen in OKT3 patients (p =
0.091).
Discussion
These observations indicate that V delta 1(+)CD4(-)Cd8(-)cytotoxic T cells
are associated with lower relapse rates and improved survival, and thus may
have a role in a graft-versus-leukemia effect.